PRINCIPAL: A prospective observational study of real world treatment patterns and treatment outcomes in patients with advanced or metastatic renal cell carcinoma receiving pazopanib (115232)

02/04/2014
01/04/2024
EU PAS number:
EUPAS6239
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

veg115232-protocol-redacted

English (787.39 KB - PDF) View document
Updated protocol

veg115232-protocol-amend-redact

First published: 22/02/2024
English (1.06 MB - PDF) View document
Study results
Study results

PZP034A2401 CSR_Redacted_PDF_A

English (450.76 KB - PDF) View document
Study report
Other information